Literature DB >> 33382687

SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.

Sanja Matic1, Suzana Popovic2, Predrag Djurdjevic3,4, Danijela Todorovic5, Natasa Djordjevic6, Zeljko Mijailovic7,8, Predrag Sazdanovic9,10, Dragan Milovanovic6,11, Dejana Ruzic Zecevic6,11, Marina Petrovic3,12, Maja Sazdanovic13, Nenad Zornic14,15, Vladimir Vukicevic15, Ivana Petrovic16, Snezana Matic16, Marina Karic Vukicevic17, Dejan Baskic2,18.   

Abstract

Clinical manifestations of SARS-CoV-2 infection range from mild to critically severe. The aim of the study was to highlight the immunological events associated with the severity of SARS-CoV-2 infection, with an emphasis on cells of innate immunity. Thirty COVID-19 patients with mild/moderate symptoms and 27 patients with severe/critically severe symptoms were recruited from the Clinical Center of Kragujevac during April 2020. Flow cytometric analysis was performed to reveal phenotypic and functional alterations of peripheral blood cells and to correlate them with the severity of the disease. In severe cases, the number of T and B lymphocytes, dendritic cells, NK cells, and HLA-DR-expressing cells was drastically decreased. In the monocyte population proportion between certain subsets was disturbed and cells coexpressing markers of M1 and M2 monocytes were found in intermediate and non-classical subsets. In mild cases decline in lymphocyte number was less pronounced and innate immunity was preserved as indicated by an increased number of myeloid and activated dendritic cells, NK cells that expressed activation marker at the same level as in control and by low expression of M2 marker in monocyte population. In patients with severe disease, both innate and adoptive immunity are devastated, while in patients with mild symptoms decline in lymphocyte number is lesser, and the innate immunity is preserved.

Entities:  

Year:  2020        PMID: 33382687     DOI: 10.1371/journal.pone.0241097

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  11 in total

Review 1.  Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology.

Authors:  Amy S Codd; Stephanie J Hanna; Ewoud B Compeer; Felix C Richter; Eleanor J Pring; Ester Gea-Mallorquí; Mariana Borsa; Owen R Moon; D Oliver Scourfield; Awen M Gallimore; Anita Milicic
Journal:  Oxf Open Immunol       Date:  2021-07-15

2.  Monocyte distribution width as a novel sepsis indicator in COVID-19 patients.

Authors:  Laila Alsuwaidi; Saba Al Heialy; Nahid Shaikh; Firas Al Najjar; Rania Seliem; Aaron Han; Mahmood Hachim
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

Review 3.  Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function.

Authors:  Ehsan Ahmadi; Zahra Bagherpour; Elmira Zarei; Azadeh Omidkhoda
Journal:  Pathol Res Pract       Date:  2022-01-29       Impact factor: 3.250

4.  Cytokine producing ability of peripheral blood cells from COVID-19 patients after unspecific in vitro stimulation.

Authors:  Snezana Zivancevic-Simonovic; Danijela Jovanovic; Vojislav Cupurdija; Olivera Milosevic-Djordjevic; Marijana Stanojevic; Milos Marinkovic; Nebojsa Igrutinovic; Ivan Stanojevic; Danilo Vojvodic; Olgica Mihaljevic
Journal:  Inflamm Res       Date:  2022-02-14       Impact factor: 4.575

Review 5.  Innate immunity to SARS-CoV-2 infection: a review.

Authors:  Marcos Jessé Abrahão Silva; Yan Corrêa Rodrigues; Karla Valéria Batista Lima; Luana Nepomuceno Gondim Costa Lima
Journal:  Epidemiol Infect       Date:  2022-07-18       Impact factor: 4.434

6.  In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19.

Authors:  Rebeca Viurcos-Sanabria; Aarón N Manjarrez-Reyna; Helena Solleiro-Villavicencio; Salma A Rizo-Téllez; Lucía A Méndez-García; Victoria Viurcos-Sanabria; Jacquelina González-Sanabria; América Arroyo-Valerio; José D Carrillo-Ruíz; Antonio González-Chávez; Jose I León-Pedroza; Raúl Flores-Mejía; Octavio Rodríguez-Cortés; Galileo Escobedo
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

Review 7.  Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.

Authors:  Pankaj Ahluwalia; Kumar Vaibhav; Meenakshi Ahluwalia; Ashis K Mondal; Nikhil Sahajpal; Amyn M Rojiani; Ravindra Kolhe
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

8.  Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients.

Authors:  Giovanni Riva; Sara Castellano; Vincenzo Nasillo; Enrico Tagliafico; Tommaso Trenti; Anna Maria Ottomano; Giuliano Bergonzini; Ambra Paolini; Beatrice Lusenti; Jovana Milić; Sara De Biasi; Lara Gibellini; Andrea Cossarizza; Stefano Busani; Massimo Girardis; Giovanni Guaraldi; Cristina Mussini; Rossella Manfredini; Mario Luppi
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.379

Review 9.  Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.

Authors:  Marianna Rowlands; Florencia Segal; Dominik Hartl
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

Review 10.  A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines.

Authors:  Domenico Galati; Serena Zanotta; Ludovica Capitelli; Marialuisa Bocchino
Journal:  Allergy       Date:  2021-07-24       Impact factor: 14.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.